WAVE Life Sciences (WVE) Misses Q1 EPS by 27c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall St set for higher open as AI stocks rise, oil slides
- Streamflation drives 39% of Americans to cancel streaming in 6 months
WAVE Life Sciences (WVE) PT Lowered to $6 at Stifel
May 14, 2021 8:47 AM EDTStifel analyst Paul Matteis lowered the price target on WAVE Life Sciences (NASDAQ: WVE) to $6.00 (from $7.00) while maintaining a Hold rating.
The analyst commented, "We are reiterating our Hold rating on Wave after a 1Q21 print that was punctuated by the... More
